Novo Nordisk and The United Laboratories International Holdings Limited Report Strong Phase 2 Results for Triple Agonist UBT251 in Type 2 Diabetes

  UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nord...

March 26, 2026 | Thursday | News
Oryon Reports Sustained Motor Improvement with Autologous Neuron Therapy in Parkinson’s

Study conducted in collaboration with the Neuroregeneration Institute at McLean Hospital Autologous neuronal cell therapy for Parkinson’s diseas...

March 24, 2026 | Tuesday | News
Eli Lilly’s Retatrutide Delivers Up to 2.0% A1C Reduction and 16.8% Weight Loss in Phase 3 TRANSCEND-T2D-1

For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 weeks in TRANSCEND-T2D-1 Participants taking retatrut...

March 23, 2026 | Monday | News
Alamar Biosciences Launches NULISAseq Neuro 220 Panel to Expand Biomarker Discovery in Neurodegenerative Diseases

New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from The Michael J. Fo...

March 18, 2026 | Wednesday | News
IFF Expands Health & Biosciences Capabilities in Latin America with New Fermentation Hub and Innovation Lab

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — is enhancing regional production an...

March 12, 2026 | Thursday | News
dsm-firmenich Completes $10 Million Modernization of Schenectady Premix Facility

dsm-firmenich, innovators in nutrition, health, and beauty, has announced the completion of a planned $10 million modernization program on its Schenectad...

March 12, 2026 | Thursday | News
Eli Lilly and Company Partners with WHO Foundation to Strengthen Global Obesity Care

The WHO Foundation announced a collaboration with Eli Lilly and Company that aims to support the WHO Foundation's global efforts to assess and strengthen...

March 09, 2026 | Monday | News
Allosteric Bioscience Advances Integrated Platform To Decode And Control Molecular Drivers Of Aging

Allosteric Bioscience, Inc. is utilizing Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular ...

March 06, 2026 | Friday | News
Ono and Congruence Deepen Strategic Discovery Alliance Beyond Oncology

Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule ...

March 04, 2026 | Wednesday | News
Novo Nordisk Expands Sogroya® Label with Three New Pediatric Growth Disorder Indications

New indications expand treatment options for appropriate children aged 2.5 years and older with Idiopathic Short Stature (ISS), born Small for Ges...

March 03, 2026 | Tuesday | News
SciBase Holding AB Secures FDA Label Expansion to Broaden Clinical Use of Nevisense in U.S. Dermatology Practices

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announced that it has received appro...

March 03, 2026 | Tuesday | News
Organon Strengthens Women’s Health Portfolio With Exclusive MIUDELLA Licensing Agreement

MIUDELLA® is a strategic addition to Organon’s portfolio, strengthening its long‑term commitment to advancing women’s health ...

February 25, 2026 | Wednesday | News
Sōlaria Biō Reports Clinical Evidence Confirming Gut Delivery and Viability of Bōndia™ Synbiotic Medical Food for Bone Health

Sōlaria Biō, a biotechnology company pioneering natural solutions for healthy aging, recently published the findings of a new open-label, randomized cl...

February 23, 2026 | Monday | Reports
Hana Health by DSS Imagetech Partners with Overture Life to Introduce Automated Egg-Freezing Technology in India

For the first time in India, couples seeking In Vitro Fertilisation (IVF) treatment for conception can rely on a globally preferred, automated egg-freezi...

February 20, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close